{"id":"W2792921896","doi":"10.1111/jdv.14878","title":"Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (<scp>SCULPTURE</scp> Extension Study)","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":193,"is_retracted":false,"has_abstract":true,"ca_institutions":"XLV Diagnostics (Canada); Probity Medical Research; Innovaderm (Canada)","funders":"Novartis Pharma; Novartis","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Psoriasis; Psoriatic arthritis; Adverse effect; Clinical trial; Internal medicine; Surgery; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002813451,0.0002395955,0.0007707766,0.0001877626,0.000144559,0.000004799717,0.0002416039,0.0002264693,0.00001034877],"category_scores_gemma":[0.0001169976,0.0001500004,0.00007250515,0.000203309,0.0004923709,0.0001005637,0.0001353445,0.0002708929,0.000006311054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003770374,"about_ca_system_score_gemma":0.00006586266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002064998,"about_ca_topic_score_gemma":0.0000125401,"domain_scores_codex":[0.9973257,0.001392355,0.0006485088,0.0002652689,0.00005740151,0.0003108065],"domain_scores_gemma":[0.9987351,0.0003330842,0.0006098883,0.0001597141,0.0001217446,0.00004042284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005814897,0.001455326,0.9688073,0.00004305094,0.001553307,0.00008723224,0.005930747,0.00007854878,0.004092316,0.0005494221,0.0004649805,0.01112287],"study_design_scores_gemma":[0.01541235,0.001572081,0.9668375,0.00009796659,0.0004296528,0.0008338004,0.0006854652,0.000002562419,0.01307271,0.0002211001,0.0007344911,0.0001003386],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977455,0.0009980961,0.00001349508,0.0003419853,0.0001931362,0.000448766,0.00002142701,0.000007285103,0.0002303716],"genre_scores_gemma":[0.9992625,0.0001966342,0.0002747294,0.00008316289,0.00003324735,0.00000329603,0.000005708716,0.00002001337,0.0001207143],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01102253,"threshold_uncertainty_score":0.6116838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01132367033045054,"score_gpt":0.2304250217205764,"score_spread":0.2191013513901259,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}